Viewpoint Capital Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Viewpoint Capital Management's MRK Position: Q3 2026 in Review
Viewpoint Capital Management increased its Merck (MRK) stake by 2.3% in Q3 2026, buying an estimated $4.98K and bringing the position to 1,568 shares worth $228K. The position accounts for 0.11% of the portfolio, ranked #99.
Viewpoint Capital Management first reported a position in MRK in Q1 2022 and has held it in 19 quarters since. The position peaked at $467K in Q2 2024. 2,434 funds tracked by Wall St. Rank hold MRK as of Q3 2026.
- Viewpoint Capital Management held 1,568 shares of Merck worth $228K as of Q3 2026.
- Viewpoint Capital Management bought 36 Merck shares in Q3 2026, an estimated $4.98K.
- Merck made up 0.11% of Viewpoint Capital Management's portfolio in Q3 2026, its #99 holding.
- Viewpoint Capital Management first reported a position in Merck in Q1 2022 and has held it in 19 quarters since.
- Viewpoint Capital Management's Merck position peaked at $467K in Q2 2024.
- 2,434 funds tracked by Wall St. Rank held Merck as of Q3 2026.
Based on Viewpoint Capital Management's 13F filing for Q3 2026, filed 27 Oct 2026.